The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 176.20
Bid: 176.20
Ask: 176.80
Change: 4.00 (2.32%)
Spread: 0.60 (0.341%)
Open: 170.00
High: 178.20
Low: 170.00
Prev. Close: 172.20
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

22 Nov 2022 07:00

RNS Number : 1299H
Forterra plc
22 November 2022

22 November 2022

FORTERRA PLC

Robust trading, FY22 expectations confirmed

Forterra plc (the 'Group'), a leading UK producer of manufactured masonry products, provides this trading update for the ten-month period ended 31 October 2022 (the 'period').

Trading

Trading in the period has remained robust with YTD sales volumes in line with prior year, reflecting ongoing production capacity constraints and record low inventory levels.

Full year results are expected to be in line with management's expectations.

Group revenue in the period was 23% ahead of the prior year driven by selling price increases implemented on 1 January, 1 April and, most recently, 1 October when we raised the majority of our brick prices by a further 16.5%. We continue to act decisively to recover ongoing cost inflation and we have notified customers of further necessary price increases effective 1 January 2023.

We have secured almost 90% of our energy requirement for the remainder of 2022. We have recently secured further 2023 positions and have now fixed approximately 60% of our full year 2023 gas requirement, (increased from c45% at the time of our last announcement) with Q1 currently c85% covered.

Strategic Investment

Commissioning of the new Desford brick factory is progressing with the first bricks having been extruded and the first of the two kilns now lit. We expect to be offering bricks from the new factory for sale to customers early in 2023 with production ramping up throughout the year. Despite the widespread inflationary pressures, we continue to expect to deliver the project within the original 拢95m budget.

Our Wilnecote brick factory closed as planned at the end of September to begin its 拢27m refurbishment and is expected to reopen in October 2023. This investment will strengthen our position in the Commercial and Specification market providing a degree of diversification beyond volume housebuilding.

Capital Allocation and Balance Sheet

Our 拢40m share buyback programme was recently completed and resulted in the repurchase of 15,843,807 shares leaving 212,803,389 shares in issue.

The Group retains a strong balance sheet with net debt before leases of approximately 拢23m at the end of October.

CEO Succession

A separate announcement regarding the appointment of our new CEO has been released this morning.

Stephen Harrison CEO commented:

"Trading remains robust although we are watchful of the impact of the recent instability in financial markets and the reported negative impact this is currently having on the housing market. The Group enters this uncertain time in a position of strength having a strong balance sheet with low levels of debt and high levels of cash generation. Inventories remain at record low levels and despite the current uncertainties we remain well-placed to mitigate the effects of a softening of demand by substituting imported bricks with domestically manufactured product."

ENQUIRIES

Forterra plc +44 1604 707 600

Stephen Harrison, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
TSTBCBDBXDDDGDB
Date   Source Headline
24th Feb 20227:00 amRNSTransaction in Own Shares
23rd Feb 20227:00 amRNSTransaction in Own Shares
22nd Feb 20227:00 amRNSTransaction in Own Shares
21st Feb 20227:00 amRNSTransaction in Own Shares
18th Feb 20227:00 amRNSTransaction in Own Shares
17th Feb 20227:00 amRNSTransaction in Own Shares
16th Feb 20228:26 amRNSHolding(s) in Company
16th Feb 20227:00 amRNSTransaction in Own Shares
15th Feb 20227:00 amRNSTransaction in Own Shares
14th Feb 20227:00 amRNSTransaction in Own Shares
11th Feb 20227:00 amRNSTransaction in Own Shares
10th Feb 20227:00 amRNSTransaction in Own Shares
9th Feb 20227:00 amRNSTransaction in Own Shares
8th Feb 20227:30 amRNSTransaction in Own Shares
8th Feb 20227:00 amRNSShare buyback programme
7th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
3rd Feb 20226:05 pmRNSEmployee Benefit Trust Share Purchase
3rd Feb 20227:00 amRNSTransaction in Own Shares
2nd Feb 20227:00 amRNSTransaction in Own Shares
1st Feb 20227:30 amRNSTransaction in Own Shares
31st Jan 20225:15 pmRNSTotal Voting Rights
31st Jan 20227:30 amRNSTransaction in Own Shares
28th Jan 20227:00 amRNSTransaction in Own Shares
26th Jan 20227:36 amRNSProgressive publishes new research
26th Jan 20227:00 amRNSPre-close trading update
6th Jan 20224:02 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20215:31 pmRNSEmployee Benefit Trust Share Purchase
25th Nov 20218:01 amRNSProgressive publishes new research
25th Nov 20217:00 amRNSTrading Update
2nd Nov 20215:12 pmRNSEmployee Benefit Trust Share Purchase
1st Nov 20211:51 pmRNSDirector Declaration
13th Oct 20217:06 amRNSHolding(s) in Company
7th Oct 20215:12 pmRNSDirector/PDMR Shareholding
6th Oct 20217:51 amRNSHolding(s) in Company
5th Oct 20215:49 pmRNSEmployee Benefit Trust Share Purchase
28th Sep 20219:28 amRNSEmployee Benefit Trust Share Purchase
23rd Sep 20218:33 amRNSHolding(s) in Company
21st Sep 20218:11 amRNSHolding(s) in Company
17th Sep 202111:21 amRNSDirector Declaration
3rd Sep 20213:22 pmRNSEmployee Benefit Trust Share Purchase
27th Aug 20212:58 pmRNSDirector/PDMR Shareholding
27th Aug 202111:15 amRNSDirector Declaration
26th Aug 20217:00 amRNSDisposal of Swadlincote site
9th Aug 20219:32 amRNSHolding(s) in Company
3rd Aug 20212:49 pmRNSEmployee Benefit Trust Share Purchase
29th Jul 20217:56 amRNSProgressive publishes new research
29th Jul 20217:00 amRNSHalf-year Report
13th Jul 20216:03 pmRNSDirector/PDMR Shareholding
5th Jul 202111:22 amRNSEmployee Benefit Trust Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.